Skip to main content

Posts

Lindsay Dudfield, Executive Director and CEO of Jindalee Resources Limited, Executed MOU with POSCO Holdings For Joint Research At McDermitt Lithium Project

JINDALEE RESOURCES LIMITED  (ASX: JRL) (Jindalee, the Company) is an Australian exploration company with Tier 1 lithium deposits in its portfolio in the United States. The Company’s core goals are to discover world-class mineral deposits and generate shareholder wealth. The United States is one of the largest marketplaces for lithium demand, and Jindalee is a leading company committed to help meet future demand. The Company is focussing efforts into developing its McDermitt lithium deposit. Jindalee Resources was listed on the Australian Securities Exchange (ASX) on 11th July 2002 and raised AUD 2.70 million. Now, it is a pure-play United States lithium company. Jindalee’s Projects: In June 2018, the Company acquired McDermitt and Clayton North, two lithium sediment projects in the United States. Both projects are 100% owned by HiTech Minerals Inc., a wholly owned, US-based subsidiary of Jindalee. Several factors attracted the Company’s interest in these projects including: Potenti...
Post a Comment
Read more

VRX Silica Limited Is All Set For The Arrowsmith North Silica Sand Project: Signed Power LOI With ResourcesWA

  VRX SILICA LIMITED   (ASX: VRX) (VRX or Company) has signed a   LETTER OF INTENT (LOI)   with ResourcesWA, a company   SPECIALISING IN ENERGY AND MINING CONSULTING . The LOI aims to explore a potential power supply solution for their Arrowsmith North Silica Sand Project by directly utilising gas from a nearby wellhead. The  OBJECTIVE  of the LOI is to assess the feasibility of setting up a powerhouse equipped with containerised gas reciprocating engines at a nearby gas wellhead location. The powerhouse would be connected to the existing gas plant through a direct offtake and reticulation to the Arrowsmith North site through a dedicated transmission line. ResourcesWA has a team with ample resources and expertise in project development, delivery, and asset management. The LOI provides a detailed proposal description and reflects the parties’ intentions for  SIX MONTHS . The proposal incorporates all design, construction, and operational requiremen...
Post a Comment
Read more

Carbonxt Group Limited And MD Mr Warren Murphy: Key Facts Regarding HY23 Results

  CARBONXT GROUP LIMITED   (ASX: CG1) (Carbonxt, or the Company) has set its sights on building a new activated carbon facility in   KENTUCKY, UNITED STATES . The Company has forged a strategic joint venture with Kentucky Coal Processing LLC to bring this plant to fruition. In the second quarter of FY 2023, the two companies will finish the engineering feasibility work for the new plant. The final legal documentation is set to conclude soon. This plant is estimated to enhance Carbonxt’s production capacity from   ~16,000 TONNES TO OVER 25,000 (+57%) . It would benefit the Company by decreasing pellet production costs and increasing margin growth. This project presents Carbonxt with an opportunity to leverage investments in pollution reduction technologies in the US market. Updates on revenue In 1H23, Cabonxt’s revenue stood at  AUD 8.9 MILLION , which  DECLINED 10%  compared to  AUD 9.9 MILLION  in 1H22. Revenue dropped due to maintenance for...
Post a Comment
Read more

VRX Silica Performance In The First Half Of The Financial Year 2023

VRX SILICA LIMITED  (ASX: VRX or Company) is a mineral exploration company that is developing high-quality silica sand projects. Silica sand is used in various industrial applications, including glassmaking, foundry moulds, and construction. The Company is developing several  SILICA SAND PROJECTS  in Western Australia, with significant tonnes of resources. VRX is committed to sustainable and responsible mining practices and strongly focuses on environmental stewardship and community engagement. This report provides an update on the Company’s financial performance, projects and operations, market analysis, and plans for the first half of the financial year 2023. Financial Performance VRX SILICA LTD  is a silica sand exploration and development company based in Western Australia. The group divided its operation into two reportable segments, development assets and Exploration and evaluation assets for management purposes. During the first half of 2023, the Company repor...
Post a Comment
Read more

Platina Resources Limited Publishes Its Half-Yearly Interim Financial Report For The Period Ended On December 31st, 2022

PLATINA RESOURCES LIMITED  (ASX: PGM), (PGM or Company) is a gold-focused mineral exploration company based in Perth, Western Australia. The Company has released its  INTERIM FINANCIAL REPORT  for the half-year period ended on December 31st, 2022. The report states the Company has preserved shareholder value by advancing its projects through exploration, feasibility, permitting, and monetising through joint ventures, sales, or development. Income Statement of the Company During the Period The Company operates predominately in mineral exploration zone and has only a reportable geographical segment, Australia. The revenue of Platina Resources during the half-year period that ended on December 31st, 2022, was  AUD 0.01 MILLION  and incurred net losses of  AUD 6.31 MILLION . Financial Position of the Company During the Half-Year Period ·          According to the interim financial report, Platina Resources has nea...
Post a Comment
Read more

VRX Silica Reports A Productive December 2022 Quarter

Here is an overview of VRX Silica’s progress during the December 2022 quarter. Critical Minerals Publication The Austrade Critical Minerals Prospectus 2022 Edition, published by the Australian Trade and Investment Commission, included  VRX SILICA’S  Arrowsmith North and Muchea silica sand projects. So far, the critical minerals prospectus has gained compelling recognition among interested foreign investors and buyers, Australian corporates, and the Australian government. The prospectus highlighted the potential of VRX Silica’s silica sand projects to address anticipated production shortfalls, build supply chain security, and aid a net-zero future, which can be a significant step forward for the Company. The publication will also promote VRX products to potential buyers and investors overseas. VRX Silica will continue to contact potential buyers who received samples of products from Arrowsmith North and Muchea silica sand projects. Silica Sand Project Advancements VRX  ens...
Post a Comment
Read more

Calima Energy And CEO Jordan Kevol Are All-Set For The Strategic Retesting Program In Montney

CALIMA ENERGY  (ASX: CE1)  unveils the initiation of an effective testing program on the two long-reach horizontal Montney wells drilled and partially tested in 2019 on the Calima Lands. With this, Calima Energy and  CEO JORDAN KEVOL  intend to de-risk the project and are expected to generate a higher value for the asset, aiming to complete a joint venture, partnership, or trade sale. The operation of one of the top-tier mining companies in Australia will gauge the gas and condensate flow rates of the Middle Montney Formation in Calima #2. In addition, it will allow for a longer-term test on the Upper Montney in the Calima #3 well. The abundance of condensate and NGLs will further upscale the project economics for prospective  CALIMA ENERGY PROJECTS . Currently, the project is funded by cash flow derived from the production activities in the Brooks and Thorsby assets, with current production of around 4,500 boe/d. The latest Calima Energy share price is  AU...
Post a Comment
Read more

Roquefort Therapeutics Reports In-Vivo Safety For Midkine Oncology Antibodies

ROQUEFORT THERAPEUTICS (LSE: ROQ, OTCQB: ROQAF)  (“Roquefort” or the “Company”)  ANNOUNCES  that two of its Midkine (MDK) antibody programs, ROQ-A1 and ROQ-A2, demonstrate  in-vivo  safety in the pre-clinical development programs. The pre-clinical programs were carried out by leading cancer research groups. ROQ-A1 and ROQ-A2 are two patented antibody medicines designed by Roquefort to target metastatic breast cancer and metastatic lung cancer. The experiments demonstrated that ROQ-A1 and ROQ-A2 bind specifically to MDK receptors in cancerous cells in the breast and lung and kill cancer  in vitro . Antibody programs targeting metastatic lung and breast cancer commenced in Q4 2022 at Olivia Newton-John Cancer Research Institute (La Trobe University), Hawkins Laboratory Biochemistry and Genetics (La Trobe University). Both antibodies have demonstrated good safety profiles validated in  in-vivo  models. The targets and milestones were achieved within ...
Post a Comment
Read more